Na WANG et al. 2019. Comparison of the forty-eight week efficacy between telbivudine and entecavir in HBeAgpositive Asian patients with chronic hepatitis B: A meta-analysis. Turkish Journal of Gastroenterology. 24, 3 (Jul. 2019), 230–240.